The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Journal of Diabetes Investigation
(Feb 2023)
Updates of incretin‐related drugs for the treatment of type 2 diabetes
Hirotaka Araki,
Takeshi Matsumura,
Noboru Furukawa,
Eiichi Araki
Affiliations
Hirotaka Araki
Department of Metabolic Medicine, Faculty of Life Sciences Kumamoto University Kumamoto Japan
Takeshi Matsumura
Department of Metabolic Medicine, Faculty of Life Sciences Kumamoto University Kumamoto Japan
Noboru Furukawa
Department of Metabolic Medicine, Faculty of Life Sciences Kumamoto University Kumamoto Japan
Eiichi Araki
Department of Metabolic Medicine, Faculty of Life Sciences Kumamoto University Kumamoto Japan
DOI
https://doi.org/10.1111/jdi.13945
Journal volume & issue
Vol. 14, no. 2
pp. 189 – 192
Abstract
Read online
No abstracts available.
Keywords
Dipeptidyl peptidase‐4 inhibitors
Glucagon‐like peptide‐1 receptor agonists
Glucose‐dependent insulinotropic polypeptide receptor
WeChat QR code
Close
